Dolby Laboratories, Inc. (DLB) Major Shareholder Sells $6,455,000.00 in Stock

Share on StockTwits

Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of the company’s stock in a transaction that occurred on Friday, June 22nd. The shares were sold at an average price of $64.55, for a total value of $6,455,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Tuesday, June 26th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.17, for a total value of $6,217,000.00.
  • On Wednesday, June 20th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.22, for a total value of $3,261,000.00.
  • On Monday, June 18th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.31, for a total value of $6,531,000.00.
  • On Thursday, June 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $64.87, for a total value of $6,487,000.00.
  • On Monday, June 11th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $64.31, for a total value of $3,215,500.00.
  • On Friday, June 8th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $64.25, for a total value of $3,212,500.00.
  • On Wednesday, June 6th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $64.36, for a total value of $3,218,000.00.
  • On Monday, June 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.93, for a total value of $6,293,000.00.
  • On Thursday, May 31st, Dagmar Dolby sold 17,439 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.67, for a total value of $1,092,902.13.
  • On Tuesday, May 29th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.54, for a total value of $6,154,000.00.

Shares of Dolby Laboratories stock opened at $61.99 on Thursday. The company has a market capitalization of $6.44 billion, a P/E ratio of 28.18, a price-to-earnings-growth ratio of 2.23 and a beta of 0.76. Dolby Laboratories, Inc. has a fifty-two week low of $48.00 and a fifty-two week high of $74.29.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings data on Tuesday, April 24th. The electronics maker reported $0.78 earnings per share for the quarter, topping the consensus estimate of $0.64 by $0.14. The company had revenue of $301.36 million during the quarter, compared to analyst estimates of $300.37 million. Dolby Laboratories had a return on equity of 12.73% and a net margin of 7.64%. The firm’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.63 earnings per share. analysts anticipate that Dolby Laboratories, Inc. will post 2.31 EPS for the current fiscal year.

A number of institutional investors have recently modified their holdings of the stock. BlackRock Inc. lifted its stake in Dolby Laboratories by 0.8% during the fourth quarter. BlackRock Inc. now owns 3,092,122 shares of the electronics maker’s stock worth $191,712,000 after purchasing an additional 25,262 shares in the last quarter. Timucuan Asset Management Inc. FL lifted its stake in Dolby Laboratories by 0.7% during the fourth quarter. Timucuan Asset Management Inc. FL now owns 1,221,424 shares of the electronics maker’s stock worth $75,728,000 after purchasing an additional 8,110 shares in the last quarter. Allianz Asset Management GmbH lifted its stake in Dolby Laboratories by 107.3% during the first quarter. Allianz Asset Management GmbH now owns 1,167,119 shares of the electronics maker’s stock worth $74,182,000 after purchasing an additional 604,109 shares in the last quarter. Thrivent Financial for Lutherans lifted its stake in Dolby Laboratories by 0.5% during the first quarter. Thrivent Financial for Lutherans now owns 952,117 shares of the electronics maker’s stock worth $60,517,000 after purchasing an additional 4,967 shares in the last quarter. Finally, Thrivent Financial For Lutherans lifted its stake in Dolby Laboratories by 2.2% during the fourth quarter. Thrivent Financial For Lutherans now owns 947,150 shares of the electronics maker’s stock worth $58,723,000 after purchasing an additional 20,610 shares in the last quarter. Institutional investors own 53.90% of the company’s stock.

Several brokerages recently weighed in on DLB. Zacks Investment Research lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Tuesday. Barrington Research reiterated a “buy” rating and issued a $78.00 price objective on shares of Dolby Laboratories in a research report on Tuesday, May 1st. Finally, ValuEngine upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Dolby Laboratories has a consensus rating of “Hold” and an average price target of $66.50.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply